---
title: "Harleystreet Pharmaceuticals Ltd(merged) (524082) — Share Price, Financials & Analysis"
symbol: "524082"
company: "Harleystreet Pharmaceuticals Ltd(merged)"
canonical: "https://tapetide.com/stocks/524082"
isin: "INE344K01013"
bse_code: "524082"
sector: "Healthcare"
industry: "Pharmaceuticals & Biotechnology"
generated_at: "2026-09-13T19:16:09.223Z"
---

# Harleystreet Pharmaceuticals Ltd(merged) (524082)

Canonical page: https://tapetide.com/stocks/524082

## Company

- **BSE Code:** 524082
- **ISIN:** INE344K01013
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals & Biotechnology
- **Macro Sector:** Healthcare
- **Stock Type:** DELISTED
- **Face Value:** ₹10
- **F&O Eligible:** No

## Latest Price

## Key Insights

### Strengths

- Company has reduced debt.
- Company is almost debt free.

### Weaknesses

- Company has a low return on equity of 13.8% over last 3 years.

## Growth Rates

| Metric | 1Y | 3Y |
| --- | --- | --- |
| net income growth | 56% | 1% |
| revenue growth | 26% | 12% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Revenue | 1179 | 1238 | 1306 | 1374 | 1445 | 1489 | 1568 | 1671 | 1742 | 1814 | 1823 | 1861 |
| Expenses | 417 | 407 | 412 | 427 | 434 | 463 | 504 | 523 | 539 | 605 | 539 | 597 |
| Financing Profit | 69 | 64 | 63 | 47 | 73 | 34 | 5 | 20 | 19 | -24 | 57 | 27 |
| Financing Margin % | 6 | 5 | 5 | 3 | 5 | 2 | 0 | 1 | 1 | -1 | 3 | 1 |
| Other Income | 122 | 107 | 107 | 124 | 136 | 143 | 205 | 184 | 219 | 236 | 186 | 221 |
| Interest | 693 | 767 | 830 | 900 | 937 | 993 | 1059 | 1128 | 1184 | 1233 | 1227 | 1236 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 191 | 171 | 171 | 171 | 210 | 177 | 210 | 204 | 238 | 212 | 243 | 249 |
| Tax % | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 26 | 24 | 26 |
| Net Profit | 142 | 127 | 127 | 127 | 156 | 131 | 155 | 151 | 177 | 157 | 184 | 185 |
| EPS in Rs | 4.57 | 4.07 | 4.06 | 4.06 | 4.98 | 4.19 | 4.96 | 4.83 | 5.63 | 5 | 5.84 | 5.74 |
| Gross NPA % | 3.19 | 3.26 | 3.36 | 3.43 | 3.23 | 3.33 | 3.29 | 3.11 | 2.99 | 2.98 | 2.91 | 2.72 |
| Net NPA % | 1.04 | 1.19 | 1.28 | 1.22 | 1.11 | 1.18 | 1.17 | 1.18 | 1.12 | 1.22 | 1.21 | 1.1 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Sales | 3.76 | 3.97 | 3.68 | 4.46 | 5.63 |
| Expenses | 2.44 | 2.73 | 2.7 | 3.49 | 4.48 |
| Operating Profit | 1.32 | 1.24 | 0.98 | 0.97 | 1.15 |
| OPM % | 35.11 | 31.23 | 26.63 | 21.75 | 20.43 |
| Other Income | 0 | 0.01 | 0.01 | 0.05 | 0.06 |
| Interest | 0.1 | 0.06 | 0.07 | 0.07 | 0 |
| Depreciation | 0.4 | 0.39 | 0.44 | 0.46 | 0.46 |
| Profit before tax | 0.82 | 0.8 | 0.48 | 0.49 | 0.75 |
| Tax % | 30.49 | 35 | 35.42 | 28.57 | 29.33 |
| Net Profit | 0.57 | 0.52 | 0.31 | 0.35 | 0.53 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 17.92 |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Equity Capital | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
| Reserves | 0.88 | 1.4 | 1.71 | 2.06 | 2.47 |
| Borrowings | 0.75 | 0.73 | 0.43 | 0.03 | 0 |
| Other Liabilities | 1.05 | 1.3 | 1.53 | 2.38 | 1.92 |
| Total Liabilities | 3.63 | 4.38 | 4.62 | 5.42 | 5.34 |
| Fixed Assets | 2.9 | 3.13 | 3.57 | 3.47 | 3.27 |
| CWIP | 0.03 | 0.14 | 0 | 0.08 | 0.01 |
| Investments | 0.06 | 0.06 | 0.06 | 0.08 | 0.08 |
| Other Assets | 0.64 | 1.05 | 0.99 | 1.79 | 1.98 |
| Total Assets | 3.63 | 4.38 | 4.62 | 5.42 | 5.34 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | 1.11 | 0.87 | 1.06 | 0.76 | — |
| Cash from Investing Activity | -0.33 | -0.73 | -0.74 | -0.45 | — |
| Cash from Financing Activity | -0.75 | -0.02 | -0.3 | -0.4 | — |
| Net Cash Flow | 0.03 | 0.12 | 0.02 | -0.09 | — |
| Free Cash Flow | 0.78 | 0.14 | 0.32 | 0.33 | — |
| CFO/OP | 108 | 92 | 124 | 95 | — |

### Ratios

| Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 |
| --- | --- | --- | --- | --- | --- |
| Debtor Days | 9.71 | 8.27 | 14.88 | 11.46 | 14.91 |
| Inventory Days | 94.9 | 141.29 | 129.92 | 120.28 | 77.15 |
| Days Payable | 328.5 | 294.35 | 383.56 | 199.09 | 133.54 |
| Cash Conversion Cycle | -223.89 | -144.79 | -238.77 | -67.35 | -41.47 |
| Working Capital Days | -46.6 | -38.61 | -71.41 | -58.92 | -2.59 |
| ROCE % | — | 30.39 | 17.83 | 17.94 | 23.22 |

## Shareholding Pattern

### annual

| Category | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 16.19% | 15% | 14.93% | 14.88% | 14.88% | 14.86% | 14.83% | 14.77% | 14.7% | 16.24% |
| FIIs | 23.55% | 21.34% | 25.97% | 22.82% | 13.04% | 8.82% | 12.27% | 12.75% | 9.64% | 11.92% |
| DIIs | 17.06% | 24.94% | 25.11% | 35.32% | 40.54% | 38.7% | 39.88% | 29.65% | 29.18% | 32.14% |
| Public | 43.2% | 38.72% | 34% | 26.97% | 31.54% | 37.63% | 33.01% | 42.82% | 46.49% | 39.68% |
| No. of Shareholders | 178840 | 183716 | 167117 | 168981 | 178348 | 198227 | 180310 | 248471 | 234219 | 189188 |

### Quarterly

| Category | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 14.83% | 14.82% | 14.82% | 14.81% | 14.77% | 14.75% | 14.73% | 14.72% | 14.7% | 14.69% | 14.66% | 16.24% |
| FIIs | 12.27% | 12.3% | 12.74% | 13.02% | 12.75% | 14.65% | 11.06% | 10.85% | 9.64% | 11.69% | 10.49% | 11.92% |
| DIIs | 39.88% | 39.7% | 38.99% | 34.2% | 29.65% | 27.61% | 26.65% | 27.89% | 29.18% | 31.79% | 31.93% | 32.14% |
| Public | 33.01% | 33.19% | 33.46% | 37.98% | 42.82% | 43% | 47.56% | 46.53% | 46.49% | 41.82% | 42.91% | 39.68% |
| No. of Shareholders | 180310 | 170186 | 172619 | 185692 | 248471 | 242749 | 247961 | 238570 | 234219 | 209881 | 204998 | 189188 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Sell
- **Buy / Neutral / Sell:** 3 / 4 / 12

### Moving Averages — summary: **Strong Sell**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 27.18 | Sell |
| EMA (10) | 27.25 | Sell |
| SMA (20) | 28.3 | Sell |
| EMA (20) | 28.13 | Sell |
| SMA (50) | 30.8 | Sell |
| EMA (50) | 29.91 | Sell |
| SMA (100) | 32.38 | Sell |
| EMA (100) | 30.4 | Sell |
| SMA (200) | 28.22 | Sell |
| EMA (200) | 29.63 | Sell |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 35.38 | Neutral |
| MACD (12,26,9) | -1.15 | Sell |
| Stochastic (14,3,3) | 14 | Buy |
| ADX (14) | 16.43 | Neutral |
| Williams %R (14) | -88.37 | Buy |
| ATR (14) | 1.59 | High Volatility |
| ROC (12) | -8.85 | Sell |
| Stoch RSI (14) | 15.94 | Buy |
| UO (7,14,28) | 39.71 | Neutral |

## Filings & Documents

### Other Documents

| Date | Document |
| --- | --- |
| 6h - Appoint Pushan Mahapatra as independent director from Mar 10, 2026; recommended as Non-Executive Part-Time Chairman; three-year term. | [Announcement under Regulation 30 (LODR)-Change in Directorate 6h - Appoint Pushan Mahapatra as independent director from Mar 10, 2026; recommended as Non-Executive Part-Time Chairman; three-year term.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/5691ab3e-9478-47fd-8408-e41587988804.pdf) |
| 5h - The Bank has issued and allotted 30,150 equity shares of Rs.10/- each today i.e. on February 17,2026 to the employees of the Bank, pursuant to … | [Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 5h - The Bank has issued and allotted 30,150 equity shares of Rs.10/- each today i.e. on February 17,2026 to the employees of the Bank, pursuant to …](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d3022877-a953-4a11-8452-0650b50011ee.pdf) |
| 26 Feb - DCB Bank participated in Kotak Securities investor conference on Feb 26, 2026; schedule of 14 meetings shared. | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 26 Feb - DCB Bank participated in Kotak Securities investor conference on Feb 26, 2026; schedule of 14 meetings shared.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c7c4833c-57af-4e3b-820a-d1cbf3c9116e.pdf) |
| 18 Feb - Of Analysts / Institutional Investors Meeting under Regulation 30 of the SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') Date: February 26, 2026 Kotak Securities Limited … | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation 18 Feb - Of Analysts / Institutional Investors Meeting under Regulation 30 of the SEBI (LODR) Regulations, 2015 ('SEBI Listing Regulations') Date: February 26, 2026 Kotak Securities Limited …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/436a44dd-f853-46f2-9d2a-8f9cb9994046.pdf) |
| 17 Feb - Reappointment of Krishnan S. Seshadri as Whole Time Director from 13 Jun 2026 to 12 Jun 2027, subject to RBI. | [Announcement under Regulation 30 (LODR)-Change in Directorate 17 Feb - Reappointment of Krishnan S. Seshadri as Whole Time Director from 13 Jun 2026 to 12 Jun 2027, subject to RBI.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/6fa983cd-57f3-470c-a80c-f2dc5af865b6.pdf) |
| 17 Feb - Appoints Suhail Nathani as Independent Director effective Feb 18, 2026 for three years (subject to shareholder approval). | [Announcement under Regulation 30 (LODR)-Change in Directorate 17 Feb - Appoints Suhail Nathani as Independent Director effective Feb 18, 2026 for three years (subject to shareholder approval).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8937122b-3cf3-4cf8-974c-26abb7f158d0.pdf) |
| 17 Feb - Appointment of Neeta Sudhir Rege as independent director effective Feb 18, 2026 for three years, subject to shareholder approval. | [Announcement under Regulation 30 (LODR)-Change in Directorate 17 Feb - Appointment of Neeta Sudhir Rege as independent director effective Feb 18, 2026 for three years, subject to shareholder approval.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/f9618964-c63e-444b-884e-493a99f5b24c.pdf) |
| 17 Feb - Appointed Mr Shaffiq Dharamshi as Additional Non-Executive (Non-Independent) Director effective Feb 18, 2026; shareholder approval pending. | [Announcement under Regulation 30 (LODR)-Change in Directorate 17 Feb - Appointed Mr Shaffiq Dharamshi as Additional Non-Executive (Non-Independent) Director effective Feb 18, 2026; shareholder approval pending.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1a10ac41-648e-4186-b405-1479a1fb0e2d.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Oct 2025 | [Concall - Oct 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ab0687f5-ec7b-4cde-9b72-0365b04c491a.pdf) |
| Oct 2024 | [Concall - Oct 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/da2bf863-8c5e-43f1-a1d2-c16a80af43b7.pdf) |
| Oct 2016 | [Concall - Oct 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=E1F9DD50_E905_405B_92BE_E562E62DCA14_163159.pdf) |
| Oct 2015 | [Concall - Oct 2015](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48BC7F77_B937_4DFB_AEF1_F1B8740DCDB4_170112.pdf) |
| Nov 2022 | [Concall - Nov 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0f38abef-9be0-466a-935d-3612417ece18.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8d01fc0c-d09b-453a-abe6-17a5388c0209.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ce30fba1-e093-4510-bd6c-6afc7b92ccd0.pdf) |
| May 2023 | [Concall - May 2023](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1f558c64-8d02-41f7-9e97-cec456914be3.pdf) |
| May 2022 | [Concall - May 2022](https://www.bseindia.com/xml-data/corpfiling/AttachHis/90023014-14ac-435e-87f9-3b8106e6b665.pdf) |
| Mar 2020 | [Concall - Mar 2020](https://www.bseindia.com/xml-data/corpfiling/AttachHis/73af9165-0b6a-4399-b3ac-567e0a2c8d1f.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from nse | [Financial Year 2012 from nse](https://archives.nseindia.com/annual_reports/AR_DCB_2011_2012_11052012120946.zip) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/820c86f7-b191-414f-a29e-63c48109873e.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc5cd6df-6abd-4f24-b735-37ff39e17b55.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ed8a7289-b7d4-433b-8f7f-81d3da5b9260.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/73031532772.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/69058532772.pdf) |
| from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/5327720320.pdf) |
| from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/5327720319.pdf) |
| from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/5327720318.pdf) |
| from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/532772/5327720317.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T19:16:09.223Z.